​​We're delighted to announce that SGS's new bioanalytical laboratory in Shanghai opened in January 2022, and is now ready to serve customers.

This completes the first phase of the project, in which a 600 m2 bioanalytical laboratory was equipped with leading instrumentation and equipment – including a Watson LIMS system and WinNonlin software. The second phase will include the completion of a biosafety level 2 (BSL-2) laboratory, which will be ready in Q3 2022.

Bioanalytical laboratory in Shanghai

The GLP-compliant laboratory follows ICH, NMPA, FDA and EMA principles. Its expert staff can design test plans tailored to customers' needs, carry out biological sample analysis and provide comprehensive data analysis reports.

SGS is now well placed to serve the bioanalytical needs of organizations in the region, whether they are engaged in preclinical or clinical trials. By working with SGS's Shanghai laboratory, organizations can not only gather critical data, but can also reduce costs, submit successful drug declarations and ultimately get their products to market quickly and safely.

Laboratory equipments

Michael Lindsay, Global Scientific Director, said: "The Chinese drug development market is booming. Thanks to the opening of our new bioanalytical laboratory, SGS is set to play a key role in supporting local and global pharmaceutical and biopharmaceutical drug development."

Advantages of Using SGS's Shanghai Bioanalytical Laboratory

  • Harmonized processes with existing global bioanalytical services
  • Access to local experts, expediting the drug development process
  • Reports can be used for multinational declarations
  • An exceptional team with bioanalytical experience in studying liposomes, albumin binding, proteins, peptides, small nucleic and poly-nucleic acids and endogenous biomarkers, including cytokines
  • Industry-leading equipment and systems, including API 6500 Plus, UPLC, MESOTM Sector S600 and MD SpectraMax M5 systems; a Watson LIMS platform; and a GLP quality system

Wai Lam, Health Science Director SGS China, commented, "This new state-of-the-art facility, backed up by SGS's global network of laboratories, will be at the forefront of bioanalytical testing in China. Our scientific experts can't wait to get started."

For more information, please contact:

Aaron Wang
Head of Business Development
Health Science SGS China
tel: +86 21 6064 5078

Geng Lu
Lab Manager
SGS China
tel: +86 21 6140 2666

About SGS

We are SGS – the world’s leading testing, inspection and certification company. We are recognized as the global benchmark for quality and integrity. Our 96,000 employees operate a network of 2,600 offices and laboratories, working together to enable a better, safer and more interconnected world.